The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Baclopar 10 mg Tablets

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/195/001

Main Information

Trade NameBaclopar 10 mg Tablets
Active SubstancesBaclofen
Dosage FormTablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/195/001

Group Information

ATC CodeM03BX Other centrally acting agents
M03BX01 baclofen


Licence Issued21/11/1989
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back